Europe · Regional markets · L'Agefi Suisse

Alcon rachète l'américain Neurotech pour 550 millions de dollars

Published by L'Agefi Suisse · Switzerland 10 h ago

L’opération permet au groupe genevo-texan de renforcer son portefeuille dans les maladies oculaires rares avec Encelto, un traitement approuvé aux Etats-Unis.

Read the full article on L'Agefi Suisse Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (agefi.com)

Also worth reading

This is Money

National Express owner eyes takeover by Spanish shareholder in fresh blow to the City

City A.M.

Alcon rachète l'américain Neurotech pour 550 millions de dollars

Share

Also worth reading

National Express owner eyes takeover by Spanish shareholder in fresh blow to the City

Halfords shares hit speedbump despite accelerating sales

Ashtead Technology agrees to £500mn takeover

Two Wealth expands partner team with another experienced banker

How the “Permanent Portfolio” strategy can help protect your wealth

Puma: Anta Sports übernimmt Vorsitz im Aufsichtsrat